Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.24 USD | -0.33% | +1.67% | -4.99% |
Mar. 04 | Armata Pharmaceuticals Secures $35 Million Credit Agreement From Innoviva Unit | MT |
Mar. 04 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2024 * | 301M | Sales 2025 * | 334M | Capitalization | 964M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.83 x |
Net Debt 2024 * | 187M | Net Debt 2025 * | 106M | EV / Sales 2025 * | 3.21 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 112 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.34% |
Latest transcript on Innoviva, Inc.
1 day | -0.33% | ||
1 week | +1.67% | ||
Current month | -0.26% | ||
1 month | -0.72% | ||
3 months | -5.98% | ||
6 months | +15.19% | ||
Current year | -4.99% |
Managers | Title | Age | Since |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 20-05-19 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 23-08-20 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 14-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-02-11 | |
Director/Board Member | 53 | 22-12-31 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 18-02-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.46% | 29 M€ | +0.33% | ||
0.40% | 26 M€ | +0.78% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 15.24 | -0.33% | 490,248 |
24-03-27 | 15.29 | +2.07% | 370,303 |
24-03-26 | 14.98 | -0.73% | 527,022 |
24-03-25 | 15.09 | 0.00% | 386,590 |
24-03-22 | 15.09 | +0.67% | 888,906 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-4.99% | 964M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |